Cargando…
Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay
Coronavirus disease 2019 (COVID-19), a disease caused by the novel betacoronavirus (SARS-CoV-2) has become a global pandemic threat. COVID-19 caused by SARS-CoV-2 is reported to originate in December 2019 in Wuhan, China and spreading rapidly around world. SARS-CoV-2 is structurally similar to the o...
Autores principales: | Galassi, Giuliana, Marchioni, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018746/ https://www.ncbi.nlm.nih.gov/pubmed/33811309 http://dx.doi.org/10.1007/s13760-021-01612-6 |
Ejemplares similares
-
Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
por: Galassi, Giuliana, et al.
Publicado: (2021) -
Reply to Letter response to “The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis”
por: Galassi, Giuliana, et al.
Publicado: (2022) -
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain–Barré syndrome
por: Galassi, Giuliana, et al.
Publicado: (2020) -
The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis
por: Galassi, Giuliana
Publicado: (2022) -
Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead
por: Galassi, Giuliana, et al.
Publicado: (2022)